Anticoagulant therapy in very old patients

Area of Science:

• Geriatrics
• Pharmacology
• Neurology

Background:

• Older adults are less likely to receive anticoagulation and are prone to underanticoagulation.
• Warfarin use is increasing in the elderly, but less than half of eligible patients utilize it.
• Stroke recurrence in patients on oral anticoagulation is primarily ischemic.

Purpose of the Study:

• To review the challenges and considerations of anticoagulation in older patients.
• To discuss the risks of hemorrhagic complications and clinical decision-making tools.
• To explore the potential impact of novel anticoagulant drugs on current treatment paradigms.

Main Methods:

• Literature review of studies on anticoagulation in the elderly.
• Analysis of evidence regarding stroke recurrence and bleeding risks.
• Discussion of clinical criteria for anticoagulation initiation.
• Evaluation of emerging anticoagulant therapies.

Main Results:

• Older patients face barriers to anticoagulation and are often underdosed.
• Hemorrhagic complications from oral anticoagulation are linked to overdosing.
• Risk factors and clinical criteria for managing anticoagulation in the elderly have been identified.
• New anticoagulant drugs show promising results, potentially supplanting vitamin K antagonists.

Conclusions:

• Optimizing anticoagulation in older adults is crucial for preventing ischemic stroke.
• Careful patient selection and monitoring are essential to minimize bleeding risks.
• Novel anticoagulants may offer improved safety and efficacy profiles for elderly patients.
• The landscape of anticoagulation therapy is evolving, with potential shifts away from warfarin.